CALCOCO2 and myeloid sarcoma: Sequencing of peripheral blood mononuclear cells from 203 MS patients and 1000 healthy controls identified a natural variant (G140E) in the autophagy receptor CALCOCO2/NDP52, which was significantly associated with reduced MS susceptibility [147].